| | |
ASPsiRNA information |
siRNA Id: | aspsirna0803
|
siRNA Name: | SHP2
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | ACCUAAGGUACAAGUACUC
|
ASP-siRNA (As strand 3'->5'): | AGCUAAGGUACAAGUACUC
|
Mismatch position in siRNA: | G18C |
Gene Information |
Gene Name | Cu,Zn superoxide dismutase (SOD1) |
Target Sequence (5'->3'): | GGATTCCATGTTCATGAGTTTGGAGATAA
|
Wild allele (5'->3'): | UGGAUUCCAUGUUCAUGAG
|
Mutant allele (5'->3'): | UCGAUUCCAUGUUCAUGAG
|
Position of siRNA on target gene: | 280-298
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_000454.4 |
Cytogenic location: | 21q22.1 |
Chromosomal coordinates: | 21:33,031,934-33,041,243 |
UniProt ID: | P00441 |
HUGO ID: | 11179 |
Reference SNp(RefSNP): | rs12191243 |
Disease/Mutation information |
Target Mutation: | c.281G>C,p.Gly94Ala
|
Matation type/variant: | Single nucleotide variant/Missense variant
|
Mutation at gene level: | NG_008689.1:g.12678G>C
|
Pathogenic status of mutation: | Pathogenic
|
Disease: | Amyotrophic Lateral Sclerosis (ALS) |
Clinical Resources |
ClinVar ID: | 14760 |
KEGG disease ID: | H00058 |
OMIM ID: | 105400 |
COSMIC: | SOD1 |
DECIPHER: | SOD1 |
GeneTests: | SOD1 |
ASP siRNA details |
Mutant allele (5'->3'): | UCGAUUCCAUGUUCAUGAG
|
ASP-siRNA (As strand 3'->5'): | AGCUAAGGUACAAGUACUC
|
Percentage efficacy of ASP-siRNA for mutant allele: | 50
|
Wild allele (5'->3'): | UGGAUUCCAUGUUCAUGAG
|
ASP-siRNA (As strand 3'->5'): | AGCUAAGGUACAAGUACUC
|
Percentage efficacy of ASP-siRNA for wild allele: | 42
|
Relative difference: | 8
|
Wild siRNA details |
Wild allele (5'->3'): | UGGAUUCCAUGUUCAUGAG
|
Wild siRNA (As strand 3'->5'): | ACCUAAGGUACAAGUACUC
|
Percentage efficacy of wild siRNA for wild allele: | NA
|
Wild allele (5'->3'): | UGGAUUCCAUGUUCAUGAG
|
ASP-siRNA (As strand 3'->5'): | AGCUAAGGUACAAGUACUC
|
Percentage efficacy of Wild sirna for mutant allele: | NA
|
Relative difference : | NA
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | HEK293 |
Experimental technique used: | Western blot |
Transfection method: | RNAiMAX |
siRNA expression method: | Dharmacon |
Post-transfection duration: | 168 hours |
Concentration used: | 300nM |
Reference: | 15768029 |
Delivery method: | Transfection |
'Article title: | Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients. |
'Authors: | Pfister EL, Kennington L, Straubhaar J, Wagh S, Liu W, DiFiglia M, Landwehrmeyer B, Vonsattel JP, Zamore PD, Aronin N. |
'Journal Reference: | Curr Biol. 2009 May 12;19(9):774-8. doi: 10.1016/j.cub.2009.03.030. Epub 2009 Apr 9. |
'